tiprankstipranks

New Portfolio - New Portfolio

James Robinson

New Portfolio
Individual Investor
Ranked #298,484 out of 781,066 TipRanks' Investors
Success Rate
54%
163 out of 300
profitable transactions
Average Return
6.44%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 0.48%
6-Month Return▼ 12.43%
12-Month Return▲ 10.38%
YTD Return▲ 0.75%
Total Return▼ 15.78%

Best Trade

Opened at
Closed at-
Gain▲ 382.26%

Bio

This is my investment portfolio, I am a long term investor, although, their are times i make swing trades. I started investing 5 yrs ago.

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▲ 6.67%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 4.85%
Jul 2024
▼ 13.14%
▲ 2.34%
▼ 5.35%
Aug 2024
▲ 2.93%
▲ 2.10%
▼ 5.58%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 2.42%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 6.16%
Nov 2024
▲ 5.93%
▼ 2.41%
▼ 3.70%
Dec 2024
▲ 9.79%
▲ 0.95%
▲ 0.75%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▲ 6.67%
▲ 8.13%▲ 1.21%▲ 4.85%
▼ 13.14%▲ 2.34%▼ 5.35%
▲ 2.93%▲ 2.10%▼ 5.58%
▲ 10.00%▼ 0.89%▼ 2.42%
▲ 26.04%▲ 5.96%▲ 6.16%
▲ 5.93%▼ 2.41%▼ 3.70%
▲ 9.79%▲ 0.95%▲ 0.75%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Erasca
▲ 18.44%
2
Close
Sep 18, 2024
Fulcrum Therapeutics
▼ 56.34%
4
Close
Sep 18, 2024
Gladstone Capital
▲ 0.69%
2
Close
Sep 18, 2024
Immunic
▲ 26.58%
3
Close
Sep 18, 2024
Palantir Technologies
▲ 17.93%
2
Close
Sep 18, 2024
Robinhood Markets
4.89%
▲ 62.48%
6
Sell
Sep 02, 2024
Annexon Biosciences
▼ 1.54%
5
Close
Sep 02, 2024
Global X NASDAQ 100 Covered Call ETF
▲ 7.26%
2
Close
Sep 02, 2024
VICI Properties
▲ 12.25%
3
Close
Sep 02, 2024
Citius Pharmaceuticals
▼ 30.49%
2
Close
Sep 02, 2024
Tilray
▲ 3.43%
6
Close
Aug 26, 2024
SNDL
0.9%
▼ 17.51%
4
Buy
Aug 26, 2024
Microsoft
4.36%
▲ 22.67%
4
Buy
Aug 26, 2024
Meta Platforms
3.11%
▲ 94.06%
4
Buy
Aug 26, 2024
Alphabet Class A
1.99%
▲ 54.34%
4
Buy
Aug 26, 2024
Nvidia
7.08%
▲ 213.63%
4
Buy
Aug 26, 2024
Advanced Micro Devices
2.47%
▲ 1.80%
4
Buy
Aug 26, 2024
Oracle
1.64%
▲ 42.72%
3
Buy
Aug 26, 2024
Adverum Biotechnologies
5.28%
▼ 50.76%
5
Buy
Aug 26, 2024
Crispr Therapeutics AG
4.94%
▼ 29.81%
3
Buy
Aug 26, 2024